XML 39 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Summary of Financial Instruments Measured at Fair Value on Recurring Basis

The following tables summarize the Company’s financial instruments measured at fair value on a recurring basis (in thousands):

 

 

 

 

 

 

 

Fair Value Measurements At

Reporting Date Using

 

 

 

Total

 

 

Quoted

Prices in

Active

Markets

For

Identical

Assets

(Level 1)

 

 

Significant

Other

Observable

Inputs

(Level 2)

 

 

Significant

Unobservable

Inputs

(Level 3)

 

As of December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

27,136

 

 

$

 

 

$

27,136

 

 

$

 

Corporate debt securities

 

 

26,506

 

 

 

 

 

 

26,506

 

 

 

 

U.S. government and agency securities

 

 

18,141

 

 

 

 

 

 

18,141

 

 

 

 

Total assets measured at fair value

 

$

71,783

 

 

$

 

 

$

71,783

 

 

$

 

As of December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

9,694

 

 

$

 

 

$

9,694

 

 

$

 

Corporate debt securities

 

 

24,781

 

 

 

 

 

 

24,781

 

 

 

 

Asset backed securities

 

 

5,508

 

 

 

 

 

 

5,508

 

 

 

 

Total assets measured at fair value

 

$

39,983

 

 

$

 

 

$

39,983

 

 

$

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock warrant liability

 

$

184

 

 

$

 

 

$

 

 

$

184

 

Summary of Assumptions Used in Black-Scholes Option Pricing Model to Determine Fair Value of Warrant Liability

The assumptions used in the Black-Scholes option pricing model to determine the fair value of the warrant liability were as follows:

 

 

 

September 15,

2020

(Conversion

Date)

 

 

December 31,

2019

 

Fair value of underlying preferred stock

 

$

13.00

 

 

$

9.79

 

Exercise price

 

$

10.812

 

 

$

10.812

 

Risk-free interest rate

 

 

0.7

%

 

 

1.9

%

Expected volatility

 

 

93.3

%

 

 

80.0

%

Expected term (in years)

 

 

9.0

 

 

 

9.7

 

Expected dividend yield

 

 

 

 

 

 

Summary of Reconciliation of Warrant Liability Measured at Fair Value Using Level 3 Significant Unobservable Inputs

The following table provides a reconciliation of the warrant liability measured at fair value using Level 3 significant unobservable inputs (in thousands):

 

 

 

Warrant

Liability

 

Balance at December 31, 2019

 

$

184

 

Change in fair value of warrant liability

 

 

75

 

Conversion to common stock warrant upon completion of IPO

 

 

(259

)

Balance at December 31, 2020

 

$